Three babies fell ill after consuming the same formula, triggering a nationwide recall.
Three infants in California, Washington, and Pennsylvania were hospitalized this June after consuming the same organic baby formula, a convergence of illness that prompted a nationwide recall and a quiet reckoning with the fragility of trust placed in products designed for the most vulnerable. Nara Organics has voluntarily pulled its powdered infant formula from shelves and websites, even as laboratory testing has yet to confirm the presence of the bacterium responsible. All three babies recovered, but the episode reminds us that the distance between safety and catastrophe can be measured in a lot number printed on the bottom of a can.
- Three infants across three states fell ill with infant botulism — a disease capable of causing respiratory arrest — after consuming the same brand of organic powdered formula.
- The recall has sent parents rushing to check lot numbers on cans already in their homes, unsure whether the formula they trusted has put their child at risk.
- Botulism's early symptoms — constipation, a weakened cry, drooping eyelids — are easy to miss, raising the stakes for families who may not yet know to be alarmed.
- Nara Organics has pulled all whole milk infant powdered formula as a precaution, even though lab testing has not confirmed bacterial contamination in any tested lot.
- Refund pathways are open through Nara.com and Target, but the deeper investigation into how contamination occurred remains unresolved.
Three infants — one each in California, Washington, and Pennsylvania — were hospitalized with infant botulism after being fed Nara Organics Powdered Infant Formula, a product sold at Target stores and through Nara.com. All three recovered, and no deaths were reported. On June 14, 2026, the FDA announced a voluntary recall after the CDC confirmed the link between the cases and the formula. Three specific lot numbers were identified as the products consumed by the sickened babies, with the numbers printed on the bottom of each can for easy verification.
What makes the recall notable is that laboratory testing has not detected Clostridium botulinum — the bacterium behind infant botulism — in any of the tested formula lots. Despite this, the company chose to recall all whole milk infant powdered formula products, a precautionary decision that reflects how seriously manufacturers must treat even unconfirmed contamination risks when infants are involved.
Infant botulism is a disease that moves quietly at first. Constipation appears early, followed by poor feeding, drooping eyelids, and a weakened cry. As it progresses, infants lose muscle tone and may struggle to breathe. It can be fatal, though prompt medical treatment has dramatically improved outcomes.
Nara has established refund channels for affected customers — automatic refunds for Nara.com purchases made between May and June 2026, and return options at any Target location. Parents whose babies consumed the formula and are showing any warning signs are urged to contact a healthcare provider immediately. The investigation into how the contamination occurred is ongoing, and the three recovered infants stand as both a warning and a measure of how much depends on swift, transparent response when infant safety is at stake.
Three infants in separate states fell ill after consuming the same organic baby formula, triggering a nationwide recall that has left parents scrambling to understand what went wrong and whether their own children are at risk. The babies—one each in California, Washington, and Pennsylvania—were hospitalized with infant botulism after being fed Nara Organics Powdered Infant Formula, a product sold widely at Target stores and through Nara.com. All three have recovered, and no deaths have been reported, but the incident has exposed a vulnerability in how infant nutrition reaches American families.
The Food and Drug Administration announced the voluntary recall on June 14, 2026, after the Centers for Disease Control and Prevention confirmed the connection between the three cases and the formula. The company identified three specific lot numbers—709125280E14F2, 709125288E14F2, and 708125174E14F2—as the products consumed by the sickened infants. Lot numbers appear on the bottom of the cans, making them relatively easy for consumers to check. Notably, laboratory testing has not detected Clostridium botulinum, the bacterium responsible for infant botulism, in any of the tested formula lots. Yet the company has chosen to recall all whole milk infant powdered formula products as a precaution, a decision that speaks to the seriousness with which manufacturers must treat even unconfirmed contamination risks when infants are involved.
Infant botulism develops when bacterial spores colonize a baby's intestinal tract and produce neurotoxins that attack the nervous system. The disease progresses insidiously: constipation often appears first, followed by poor feeding, drooping eyelids, sluggish pupils, and a distinctive weak or altered cry. As the condition worsens, affected infants lose muscle tone, struggle to swallow, and may experience difficulty breathing. In severe cases, respiratory arrest becomes possible. The disease can be fatal, though modern medical care has transformed outcomes for infants who receive prompt treatment.
Nara issued a statement through the FDA saying the company is "taking aggressive action" and working closely with federal and state health authorities to investigate the root cause of the contamination. The company has set up refund mechanisms for affected customers: those who purchased formula from Nara.com between May and June 2026 will receive automatic refunds, while other online buyers can request refunds through the website. Consumers who bought the product at Target can return it to any store or seek a refund through Target's website.
For parents who purchased this formula, the immediate action is clear: stop using the product and obtain a refund. For those whose babies have consumed it and are showing any of the warning signs—constipation, feeding difficulties, muscle weakness, or changes in cry or breathing—the guidance is equally urgent: contact a healthcare provider immediately. The recall affects only formula sold within the United States, though the company's distribution network suggests the product reached families across the country. As health authorities continue their investigation into how contamination occurred, the three recovered infants serve as both a cautionary tale and a reminder that even organic, carefully marketed products can pose unexpected risks to the most vulnerable consumers.
Notable Quotes
Nara is taking aggressive action to ensure the safety of the babies and families who use the product as we work closely with the FDA, CDC, and state partners to support their investigation.— Nara Organics statement to the FDA
The Hearth Conversation Another angle on the story
Why would a company recall an entire product line when the bacteria hasn't actually been found in the formula?
Because when three babies get sick from the same product, you can't afford to wait for perfect certainty. The reputational and legal risk of another case is enormous, but more than that—you're talking about infants. The precaution becomes the only rational choice.
How does botulism even get into baby formula in the first place?
That's what investigators are trying to figure out. It could be contamination during manufacturing, in the raw milk used, during packaging, or even in storage. With powdered formula, spores can survive the drying process, which is why this is taken so seriously.
The source says no lots tested positive for the bacteria. So how do they know it was the formula?
The epidemiology is strong enough. Three babies in three different states, all fed the same product, all developed the same rare disease. That pattern is the evidence, even without finding the organism in the can.
What happens to a baby with botulism?
It's a slow paralysis, essentially. The toxin blocks nerve signals to muscles. A baby stops feeding well, becomes floppy, cries weakly. If it reaches the respiratory muscles, the baby can't breathe on their own. These three were caught and treated in time.
Is this the first time this has happened with infant formula?
No. There was a larger outbreak tied to another formula brand that sickened over 50 babies across 19 states. So this is a known risk, which is why the response here is so swift and decisive.